Physician profile
Can Bas
NPI 1336911759
$3,258.77
in general payments reported to CMS, 2019-2025
7 companies · $1,404 in 2025
The $1,404 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,320 · 2024: $535 · 2025: $1,404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,659 · Travel and Lodging: $1,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,659.02 |
| Travel and Lodging | $1,599.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,491.50 | 2023-2024 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Arthrex, INC. | $1,116.53 | 2025 | |
| Kerecis Limited | $341.73 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Novus Surgical Consultants | $154.69 | 2025 | |
| Blue Surgical LLC | $84.99 | 2025 | |
| Endo USA, INC. | $35.75 | 2024-2025 | Xiaflex |
| Skeletal Dynamics INC | $33.58 | 2025 | Geminus, Implate, Ijs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Can Bas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.